Progress in Hepatitis C research

Hepatitis C has long been a problem with a low rate of cure. But new drug therapies are in use and others are on the horizon, according to Dr. Paul J. Thuluvath, chief of gastroenterology at Mercy Medical Center and the medical director of the Institute for Digestive Health & Liver Disease at Mercy. That has meant better liver health for millions in this country and around the globe.

By Meredith Cohn, The Baltimore Sun

September 8, 2011